根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001437749-23-003634 Act: 34 Size: 393 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-23-003637 Act: 34 Size: 310 KB 网页链接
$Isoray(ISR)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-23-003164 Size: 6 KB 网页链接
$Isoray(ISR)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-23-003166 Size: 5 KB 网页链接
$Isoray(ISR)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-23-003167 Size: 5 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.02 and 5.02 Accession Number: 0001437749-23-003047 Act: 34 Size: 153 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01, 1.02, 2.01, 3.02, 5.02, 5.03, 7.01, and 9.01 Accession Number: 0001437749-23-002543 Act: 34 Size: 480 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 5.07, 7.01, and 9.01 Accession Number: 0001437749-23-002010 Act: 34 Size: 172 KB 网页链接
$Isoray(ISR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-23-000956 Act: 34 Size: 36 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 5.07, 7.01, and 9.01 Accession Number: 0001437749-23-000954 Act: 34 Size: 183 KB 网页链接